The relationship between BMI and insulin resistance and progression from single to multiple autoantibody positivity and type 1 diabetes among TrialNet Pathway to Prevention participants

Diabetologia

Volumn 59, Issue 6, 2016, Pages 1186-1195

  Meah, Farah A ^a,b   DiMeglio, Linda A ^a   Greenbaum, Carla J ^c   Blum, Janice S ^a   Sosenko, Jay M ^d   Pugliese, Alberto ^d   Geyer, Susan ^e   Xu, Ping ^e   Evans Molina, Carmella ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Edward Hines Veterans Hospital   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Accelerator hypothesis; BMI; Diabetes in childhood; HOMA1 IR; Insulin sensitivity and resistance; Pancreatic autoantibodies; Pathway to Prevention; Prediction and prevention of type 1 diabetes; TrialNet; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; DISEASE COURSE; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROPHYLAXIS; UNDERWEIGHT; ADOLESCENT; CHILD; IMMUNOLOGY; INFANT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AUTOANTIBODIES; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84961223661     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3924-5     Document Type: Article

References (50)

1. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J (1999) Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia 42:1395–1403
2. DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 23:857–866
3. Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 373:2027–2033
4. Lawrence JM, Imperatore G, Dabelea D et al (2014) Trends in incidence of type 1 diabetes among non-hispanic white youth in the United States, 2002-2009. Diabetes 63:3938–3945
5. Donath MY, Hess C, Palmer E (2014) What is the role of autoimmunity in type 1 diabetes? A clinical perspective. Diabetologia 57:653–655
6. Fourlanos S, Varney MD, Tait BD et al (2008) The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31:1546–1549
7. Redondo MJ, Yu L, Hawa M et al (2001) Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354–362
8. Bodansky HJ, Staines A, Stephenson C, Haigh D, Cartwright R (1992) Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. Br Med J (Clin Res Ed) 304:1020–1022
9. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911–920
10. Schneider DA, von Herrath MG (2014) Potential viral pathogenic mechanism in human type 1 diabetes. Diabetologia 57:2009–2018
11. Vaarala O, Atkinson MA, Neu J (2008) The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555–2562
12. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500–1503
13. Kimpimaki T, Kupila A, Hamalainen AM et al (2001) The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 86:4782–4788
14. Howard SG, Lee DH (2012) What is the role of human contamination by environmental chemicals in the development of type 1 diabetes? J Epidemiol Community Health 66:479–481
15. Wilkin TJ (2008) Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis. Pediatr Diabetes 9:23–32
16. Johansson C, Samuelsson U, Ludvigsson J (1994) A high weight gain early in life is associated with an increased risk of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 37:91–94
17. Knerr I, Wolf J, Reinehr T et al (2005) The ‘accelerator hypothesis’: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 48:2501–2504
18. Dabelea D, D’Agostino RB Jr, Mayer-Davis EJ et al (2006) Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care 29:290–294
19. Kibirige M, Metcalf B, Renuka R, Wilkin TJ (2003) Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care 26:2865–2870
20. Fryar CD CM, Ogden CL (2012) Prevalence of Obesity Among Children and Adolescents: United States, Trends 1963–1965 Through 2009–2010. Available from http://www.cdc.gov/nchs/data/hestat/obesity_child_09_10/obesity_child_09_10.pdf, accessed 29 Mar 2014.
21. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP (2007) Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30:2314–2320
22. Chase HP, Cuthbertson DD, Dolan LM et al (2001) First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 138:244–249
23. Sosenko JM, Skyler JS, Mahon J et al (2011) Validation of the Diabetes Prevention Trial-type 1 risk score in the TrialNet Natural History Study. Diabetes Care 34:1785–1787
24. Sosenko JM, Skyler JS, Mahon J et al (2014) Use of the Diabetes Prevention Trial-type 1 risk score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes. Diabetes Care 37:979–984
25. Sosenko JM, Skyler JS, Mahon J et al (2012) The application of the Diabetes Prevention Trial-type 1 risk score for identifying a preclinical state of type 1 diabetes. Diabetes Care 35:1552–1555
26. Skyler JS, Greenbaum CJ, Lachin JM et al (2008) Type 1 Diabetes TrialNet--an international collaborative clinical trials network. Ann N Y Acad Sci 1150:14–24
27. Mahon JL, Sosenko JM, Rafkin-Mervis L et al (2009) The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes 10:97–104
28. Yu L, Boulware DC, Beam CA et al (2012) Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 35:1213–1218
29. Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966–1971
30. Vehik K, Beam CA, Mahon JL et al (2011) Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care 34:1897–1901
31. Sosenko JM, Mahon J, Rafkin L et al (2011) A comparison of the baseline metabolic profiles between Diabetes Prevention Trial-Type 1 and TrialNet Natural History Study participants. Pediatr Diabetes 12:85–90
32. (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685–1691
33. Ogden CL, Kuczmarski RJ, Flegal KM et al (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60
34. American Diabetes Association (2014) Standards of medical care in diabetes--2014. Diabetes Care 37(Suppl 1):S14–S80
35. Lin DY, Wei LJ, Ying Z (1993) Checking the Cox model with cumulative sums of Martingale-based residuals. Biometrika 80:557–572
36. Erlich H, Valdes AM, Noble J et al (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57:1084–1092
37. Steck AK, Armstrong TK, Babu SR, Eisenbarth GS (2011) Stepwise or linear decrease in penetrance of type 1 diabetes with lower-risk HLA genotypes over the past 40 years. Diabetes 60:1045–1049
38. Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311:806–814
39. (2000) Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet 355:873–876
40. Winkler C, Marienfeld S, Zwilling M, Bonifacio E, Ziegler AG (2009) Is islet autoimmunity related to insulin sensitivity or body weight in children of parents with type 1 diabetes? Diabetologia 52:2072–2078
41. Lamb MM, Yin X, Zerbe GO et al (2009) Height growth velocity, islet autoimmunity and type 1 diabetes development: the Diabetes Autoimmunity Study in the Young. Diabetologia 52:2064–2071
42. Cedillo M, Libman IM, Arena VC et al (2015) Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes. J Clin Endocrinol Metab 100:E82–E86
43. Lipman TH, Levitt Katz LE, Ratcliffe SJ et al (2013) Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry. Diabetes Care 36:1597–1603
44. Gimenez M, Aguilera E, Castell C, de Lara N, Nicolau J, Conget I (2007) Relationship between BMI and age at diagnosis of type 1 diabetes in a Mediterranean area in the period of 1990-2004. Diabetes Care 30:1593–1595
45. O’Connell MA, Donath S, Cameron FJ (2007) Major increase in type 1 diabetes: no support for the accelerator hypothesis. Diabet Med 24:920–923
46. Couper JJ, Beresford S, Hirte C et al (2009) Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes. Diabetes Care 32:94–99
47. Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703–707
48. Steck AK, Dong F, Wong R et al (2014) Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers. Pediatr Diabetes 15:355–362
49. Barker JM, Goehrig SH, Barriga K et al (2004) Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27:1399–1404
50. Ziegler AG, Meier-Stiegen F, Winkler C, Bonifacio E (2012) Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty--TEENDIAB: study design. Pediatr Diabetes 13:419–424